Status:
COMPLETED
Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Gastrointestinal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to learn more about the symptoms that may occur in patients with GI cancer. The types of GI cancer being studied are cancers of the stomach, liver, pancreas, colon, and rectu...
Detailed Description
Questionnaires: If you agree to take part in this study, you will be asked to complete the MDASI-GI questionnaire on Day 1. It asks about any symptoms you may be experiencing, and how those symptoms ...
Eligibility Criteria
Inclusion
- Patients must be out-patients being reviewed or treated in M. D. Anderson's Department of GI Medical Oncology.
- Patients will have received a confirmed pathological diagnosis of GI cancer (gastric cancer, liver cancer, pancreatic cancer, colorectal cancer).
- Patients will or will not be undergoing chemotherapy or treatment with other agents on the day of enrollment.
- Patients must be \> or = 18 years of age.
- Patients must be able to speak and read English.
Exclusion
- Patients who, in research staff's estimation, cannot understand the intent of the study.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT00849979
Start Date
July 1 2008
End Date
January 1 2010
Last Update
July 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030